1. Stem Cells and Regenerative Medicine
  2. Genetics and Genomics
Download icon

Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6

Correction
  • Cited 1
  • Views 482
  • Annotations
Cite this article as: eLife 2018;7:e43690 doi: 10.7554/eLife.43690

Main text

Bak RO, Dever DP, Reinisch A, Hernandez DC, Majeti R, Porteus MH. 2017. Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. eLife 6:e27873. doi: 10.7554/eLife.27873.

Published 28, September 2017

In the Material and Methods section of our originally published manuscript, we erroneously defined the concentration of the small molecule StemRegenin 1, (SR1) used for hematopoietic stem and progenitor cell culture, as 0.75mM. The correct concentration for SR1 should be 0.75µM instead of 0.75mM.

The article has been corrected accordingly.

Article and author information

Author details

  1. Daniel P Dever

  2. David Cruz Hernandez

  3. Ravindra Majeti

    For correspondence
    rmajeti@stanford.edu

Publication history

  1. Version of Record published: November 16, 2018 (version 1)

Copyright

© 2018, Bak et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 482
    Page views
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)